Baraclude 0.5mg Tablet
By Baraclude
Rx
10 Tablet in a Strip

Composition
Entecavir(0.5mg)

Manufacturer - BMS India Pvt Ltd
Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013

Expires on or after
September, 2026

liver
Baraclude 0.5mg Tablet can be used safely in patients with liver disease. It is not necessary to adjust the dosage of Baraclude 0.5mg Tablet for individuals with liver issues. This means that individuals with liver conditions can generally use this medication without needing to change the dose.

kidney
Baraclude 0.5mg Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Consult your doctor for proper guidance.

alcohol
It is not known if it is safe to drink alcohol while taking Baraclude 0.5mg Tablet. Please consult your doctor.

driving
When taking Baraclude 0.5mg Tablet, be cautious as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if these effects are experienced.

pregnancy
Baraclude 0.5mg Tablet may be harmful during pregnancy. Limited human studies show risks to the baby. Animal studies indicate potential harm. Your doctor will assess benefits and risks before prescribing. Consult your doctor.

breastfeeding
Caution is advised for breastfeeding mothers using Baraclude 0.5mg Tablet. Limited data indicates potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | Nucleoside analogue |
Therapeutic Class | - |
Action Class | - |
₹685.86
₹745.5
8% OFF
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024